Month: May 2020

Los Angeles, CA, May 11, 2020 (GLOBE NEWSWIRE) — Los Angeles, California /GLOBENEWSWIRE/- May 11, 2020. KRONOS ADVANCED TECHNOLOGIES, Inc., (OTC:KNOS) (“KNOS” or the “Company”) a product development and production company that has significantly changed the way air is moved, filtered and sterilized today announced  the appointment of Mary Tylor to the Company’s Board of Directors as an independent Director.Mary Taylor is a certified public accountant and, prior to her political career, spent 16 years in the private sector, including 12 years with Bober Markey Fedorovich, an Akron-based CPA and advisory firm. Her political background includes being on the Green City Council as well as being elected to the Ohio General Assembly and subsequently to serve as the Ohio state auditor in 2006. She also served as the...

RALEIGH, N.C., May 11, 2020 (GLOBE NEWSWIRE) — Data443 Risk Mitigation, Inc. (OTC: ATDS), a leading data security and privacy software company, today announced the release of its world leading Data Privacy solution with 30,000 active installations – WordPress GDPR Framework – for compliance with the California Consumer Privacy Act (the “CCPA”) marketplace.Why it Matters:The CCPA – already in effect; enforcement commences in July of 2020Starting in California, Data443 expands its popular offering across the USAdds the ‘Do Not Sell My Information’ option for quick and easy value for merchantsDeploys in minutesOver 100 million WordPress sites in operation in the US alone       Coming Up this Year:More enhancements lockstep with the GDPR and Global Privacy Manager product setCommercialization options will be built into the platform...

                                                                                                                                                    Company Announcement no. 56 – 2020Copenhagen, May 11th, 2020GreenMobility increases focus on own cities and ends the franchise agreement in OsloToday, GreenMobility and Vy have agreed to end their cooperation on shared electric cars in Oslo, as the franchise model does not adequately support neither of the parties’ businesses nor strategiesDuring the agreement period, GreenMobility’s strategy has shifted to increasingly focus on expanding its popular, electric car-sharing service to European cities through own operations, where GreenMobility invests and runs the business itself. The shift in strategy has been driven by an increasing need for agility and control in the launch and...

Press releaseNeuilly-sur-Seine, France – May 11, 2020  Information on number of shares and voting rights as stipulated by article 223-16 of the general regulations of the French financial markets authority AMF(1) including the new shares issued in Euroclear as a result of the exercise of stock options since January 1, 2020.                                                                                                                           AttachmentBUREAU VERITAS Number of shares and voting rights as of April 30, 2020

Communiqué de presseNeuilly-sur-Seine, France – 11 mai 2020  Information relative au nombre d’actions et de droits de vote prévue par l’article 223-16 du règlement général de l’Autorité des marchés financiers(1) y compris les actions nouvelles créées en Euroclear du fait des levées d’options de souscription d’actions intervenues depuis le 1er janvier 2020.                                                                                                                           Pièce jointeBUREAU VERITAS Nombre d’actions et droits de vote au 30 avril 2020

Paris, le 07 mai 2020Déclaration mensuelle du nombre de droits de vote et du nombre d’actions composant le capital au 30 avril 2020Conformément aux articles L233-8 du Code de commerce et 223-16 du règlement général de l’AMFSII – Eric MATTEUCCI – Tél. : 01.42.84.82.22Ces informations sont disponibles sur le site de la sociétéhttp://www.groupe-sii.comPièce jointeSII_droits_de_vote_2020_04

Delta Drone organise le renforcement de sa structure financièreSignature d’un contrat d’obligations convertibles de 1 M€ avec Ott VenturesA l’occasion de la publication du Communiqué de presse daté du 11 mai 2020, la rédaction des caractéristiques du contrat d’obligations convertibles comportait des erreurs de plume. La présente version l’annule et le remplace.Dardilly, 11 mai 2020Préambule : Risques liés à l’émission et impacts de l’opération en termes de gestion du risque de liquidité et d’horizon de financementCompte tenu d’une situation de trésorerie de 2,5 M€ à début mai 2020 post-réglement de la quasi-totalité des dettes d’exploitation échues, la mise en place de ce nouveau financement outre l’émission d’ORNAN assorties de BSA annoncée le 7 avril 2020, permet d’atteindre une capacité minimale de 12,5 M€ de trésorerie, qui correspond...

LOS ANGELES, May 11, 2020 (GLOBE NEWSWIRE) — During the six months ended March 31, 2020, Daily Journal Corporation (NASDAQ:DJCO) had consolidated revenues of $24,033,000 as compared with $21,140,000 in the prior year period.  This increase of $2,893,000 was primarily from (i) Journal Technologies’ increased license and maintenance fees of $1,285,000, consulting fees of $978,000 and public service fees of $770,000, and (ii) the Traditional Business’ increases of legal notice advertising and service fee net revenues of $215,000 and government notice advertising and service fee net revenues of $38,000, partially offset by reductions in the Traditional Business’ display advertising net revenues of $252,000 (including conferences), classified advertising net revenues of $40,000, trustee sale notice advertising net revenues of $57,000 and...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

MADRID, Spain and CAMBRIDGE, Mass., May 11, 2020 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported financial results for the first quarter of 2020 and provided an update on recent developments.Dr Carlos Buesa, Oryzon’s Chief Executive Officer, said, “Oryzon continued to advance its clinical programs in the first quarter. We are encouraged by the exciting signals of clinical efficacy observed in both our iadademstat oncology and vafidemstat neurology programs, combined with good safety and tolerability profiles.”During the last weeks of Q1 and into Q2 2020, the Covid-19 pandemic has impacted activities of pharma and biotech companies globally. As the...